News

US and UK in Talks to Resolve Dispute over Steel and Aluminum Tariffs

US and UK in Talks to Resolve Dispute over Steel and Aluminum Tariffs

Officials from the United States and the United Kingdom have entered into joint talks in an effort to resolve the trade dispute over tariffs on U.S. steel and aluminum. Representatives agreed to resolve the dispute in a joint virtual conference beginning on Jan. 20. American representatives are keen on removing…
Read More
CEOs of Multiple Major US Airlines Warn 5G Could Ground Planes

CEOs of Multiple Major US Airlines Warn 5G Could Ground Planes

Multiple CEOs from several major U.S. airlines have warned that 5G technology could cause huge disruptions to air travel by grounding planes. On Monday, a group of top airline executives warned that the nation’s commerce will essentially “grind to a halt” and there will be “significant operation disruptions” to air…
Read More
FAA Sets New Rules for Some Boeing 787 Landings Near 5G Service

FAA Sets New Rules for Some Boeing 787 Landings Near 5G Service

Federal safety officials have released new sets of rules for some Boeing 787 planes landing in areas that have 5G service. The Federal Aviation Administration (FAA) is directing operators of some Boeing planes to adopt extra procedures when landing on wet or snowy runways near impending 5G service. According to…
Read More
Insurance Companies Hit With $44 Billion in Losses during Pandemic

Insurance Companies Hit With $44 Billion in Losses during Pandemic

Insurance companies across America have been hit with $44 billion in losses during the pandemic. Insured losses and risks of newer variants emerging increased the strain on risk management companies around the world. The hit was revealed in a recent report by international insurance intermediary group Howden. Although enormous losses…
Read More
Novartis Seeks Emergency Use FDA Approval for New Covid Therapy

Novartis Seeks Emergency Use FDA Approval for New Covid Therapy

Swiss pharmaceutical corporation Novartis has announced that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to seek emergency use approval from the United States Food and Drug Administration (FDA). The comapny wishes exercise an option to in-licence the antiviral from development partner Molecular…
Read More